Gene · 3055
Papers2,931
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,931
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Skeletal muscle extramedullary plasmacytoma transformed into plasmablastic plasmacytoma: a case report. | J Cancer Res Clin Oncol | 2024 | 38300308 | PubTator, text mining | PubMed |
| Mechanism of pachymic acid in the treatment of gastric cancer based on network pharmacology and experimental verification. | World J Gastrointest Oncol | 2024 | 38292852 | PubTator, text mining | PubMed |
| The oncogenic mechanisms of the Janus kinase-signal transducer and activator of transcription pathway in digestive tract tumors. | Cell Commun Signal | 2024 | 38273295 | PubTator, text mining | PubMed |
| Analysis of MicroRNA-Transcription Factors Co-Regulatory Network Linking Depression and Vitamin D Deficiency. | Int J Mol Sci | 2024 | 38256187 | PubTator, text mining | PubMed |
| What role does GPR65 play in the progression of osteosarcoma? Its mechanism and clinical significance. | Cancer Cell Int | 2024 | 38218960 | PubTator, text mining | PubMed |
| How I use genomics and BTK inhibitors in the treatment of Waldenström macroglobulinemia. | Blood | 2024 | 38211337 | PubTator, text mining | PubMed |
| Location, location, location: Protein kinase nanoclustering for optimised signalling output. | Elife | 2024 | 38206309 | PubTator, text mining | PubMed |
| Novel lissencephaly-associated NDEL1 variant reveals distinct roles of NDE1 and NDEL1 in nucleokinesis and human cortical malformations. | Acta Neuropathol | 2024 | 38194050 | PubTator, text mining | PubMed |
| Transcriptomic analysis identifies B-lymphocyte kinase as a therapeutic target for desmoplastic small round cell tumor cancer stem cell-like cells. | Oncogenesis | 2024 | 38177125 | PubTator, text mining | PubMed |
| Mechanisms underlying therapeutic resistance of tyrosine kinase inhibitors in chronic myeloid leukemia. | Int J Biol Sci | 2024 | 38164178 | PubTator, text mining | PubMed |
| Gains of 20q11.21 in human pluripotent stem cells: Insights from cancer research. | Stem Cell Reports | 2024 | 38157850 | PubTator, text mining | PubMed |
| Osimertinib Covalently Binds to CD34 and Eliminates Myeloid Leukemia Stem/Progenitor Cells. | Cancer Res | 2024 | 38095536 | PubTator, text mining | PubMed |
| A high-throughput two-cell assay for interrogating inhibitory signaling pathways in T cells. | Life Sci Alliance | 2024 | 38073578 | PubTator, text mining | PubMed |
| Multi-omics analyses reveal bacteria and catalase associated with keloid disease. | EBioMedicine | 2024 | 38061241 | PubTator, text mining | PubMed |
| Leveraging Machine Learning Models for Peptide-Protein Interaction Prediction. | ArXiv | 2024 | 37961736 | PubTator, text mining | PubMed |
| Exploring antiproliferative activities and kinase profile of ortho-substituted N-(4-(2-(benzylamino)-2-oxoethyl)phenyl)benzamides. | Chem Biol Drug Des | 2024 | 37873688 | PubTator, text mining | PubMed |
| Bruton's Tyrosine Kinase Inhibitors with Distinct Binding Modes Reveal Differential Functional Impact on B-Cell Receptor Signaling. | Mol Cancer Ther | 2024 | 37735104 | PubTator, text mining | PubMed |
Revealing the Role of the Arg and Lys in Shifting Paradigm from BTK Selective Inhibition to the BTK/HCK Dual Inhibition - Delving into the Inhibitory Activity of KIN-8194 against BTK, and HCK in the Treatment of Mutated BTKCys481 Waldenström Macroglobulinemia: A Computational Approach. | Anticancer Agents Med Chem | 2024 | 36752293 | PubTator, text mining | PubMed |
| DMD deletions underlining mild dystrophinopathies: literature review highlights phenotype-related mutation clusters and provides insights about genetic mechanisms and prognosis. | Front Neurol | 2023 | 38288333 | PubTator, text mining | PubMed |
| Comparison of Transcriptomic Analysis of the Conjunctiva in Glaucoma-Treated Eyes with Dry Eyes and Healthy Controls. | Biomolecules | 2023 | 38254630 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3055/papers?page=6